Start with the customer pain, not the product labels. Explain how the target helps your platform solve a costly friction or unlock a constrained capability. Articulate adjacency fit, overlap risks, and integration shape so your colleagues can instantly picture where value is born.
Write objective, measurable cutoffs that keep debate short and discoveries high quality. Specify scale thresholds, unit economics, regulatory posture, product depth, and partner reliance. Commit to a small set, test against known winners and misses, and iterate weekly as patterns emerge under real deal pressure.
Lay out ownership, windows, restrictions, and renegotiation cliffs with brutal clarity. Emphasize evergreen titles, localization readiness, and metadata completeness. Catalogs that travel across platforms and geographies create option value, smoothing revenue volatility and increasing negotiation leverage when platforms change rules or markets shift underfoot.
Break down revenue by ads, subscriptions, licensing, commerce, and events. Highlight concentration risk and tactical plans to diversify. Show proof of pricing power or, at minimum, resilient renewal behavior. Mixed monetization, thoughtfully layered, reduces vulnerability to algorithm swings and makes integration synergies easier to harvest quickly.
Open with identity snapshot, decisive sentence, core metric trio, and fit rationale. Pack nothing fluffy above the fold. Executives skim on phones between flights; design for that moment. If the value lands in five seconds, the rest of your analysis earns patient reading.
Scatter small, verifiable exhibits that reduce debate: contract logos with durations, audited metrics with sources, and quotes from customers or regulators. Micro-proofs create momentum by letting skeptics test claims quickly, then move forward together, confident that the next hour will not be wasted.
Name the three scariest risks, rank them by severity and likelihood, and show concrete mitigations already in motion. Honest risk panels elevate credibility and align expectations. Boards reward adults in the room who surface uncertainty early rather than spinning glossy narratives that age poorly.
Propose a tiny set of decisive questions that, if answered negatively, save everyone months: data portability realities, contract assignment limits, latent liabilities, and cultural incompatibilities. Fast failure is kindness in deals, freeing capacity to double down on candidates with genuine, compounding mutual benefit.
Propose a tiny set of decisive questions that, if answered negatively, save everyone months: data portability realities, contract assignment limits, latent liabilities, and cultural incompatibilities. Fast failure is kindness in deals, freeing capacity to double down on candidates with genuine, compounding mutual benefit.
Propose a tiny set of decisive questions that, if answered negatively, save everyone months: data portability realities, contract assignment limits, latent liabilities, and cultural incompatibilities. Fast failure is kindness in deals, freeing capacity to double down on candidates with genuine, compounding mutual benefit.
Detail vendor consolidation, cloud economies, shared compliance tooling, and joint procurement. Then highlight capability gains like shared fraud intel or ad inventory routing. Concrete, near-term wins defend price paid and set morale early, creating political capital for harder, slower integrations that follow after initial excitement fades.
Describe cross-sell routes, channel partner overlaps, and brand transfers that reduce trust gaps. Equip sellers with a unifying story and shared proof points. When deals immediately help someone hit quota, internal advocacy grows naturally, and post-merger value creation stops being a slide and becomes a habit.
Outline identity mapping, consent management, secure data pipes, and reference architectures. Call out places to federate rather than force premature centralization. Teams appreciate pragmatic sequencing that prevents outages and shows respect for customers, while still building the connective tissue that unlocks portfolio-wide intelligence and product innovation.
All Rights Reserved.